Combination antiplatelet therapy reduces risk of recurrent stroke
A combination therapy using the blood thinner cilostazol, along with either aspirin or clopidogrel, was shown to decrease the risk of stroke recurrence...
List view / Grid view
News
FDA approval for Cablivi to treat rare clotting disorder
The FDA has approved the first specific therapy for the rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP)...
Researchers launch virtual docking library to aid drug discovery
Researchers have launched a large virtual docking library expected to grow to more than one billion molecules by 2020 which could aid drug discovery...
PDA Italy Chapter has chosen the new COO of PQE Group, Claudio Puglisi, as member of the executive committee for the role of Chapter Liaison and External Relationship
The counting of votes that saw the election of Mr. Claudio Puglisi, new COO of PQE Group, was held last January 31st in Milan, Italy...
No association found between trazodone and reduced risk of dementia
The antidepressant drug, trazodone, taken for anxiety and depression, has been found not to be linked to a reduced risk of dementia...
Micromotors used for the delivery of oral vaccines
Researchers have developed a method of using micromotors to deliver oral vaccines in an attempt to break away from widely used injections...
PharmaFluidics’ new product launch steers ‘on-a-chip’ separations of complex biological samples to new heights
PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way of performing separations by creating nano-LC columns on a silicon chip...
Interphex New York: FPS confirm their presence for 2019
FPS Food and Pharma Systems is a leading company in the pharmaceutical and fine chemical fields, developing, manufacturing and installing worldwide its own range of fine size reduction machines and containment solutions (sterile and highly toxic API)...
Vaccines and infectious diseases in the ageing population project begins
The VITAL project addresses the challenges to medicines for the ageing population, with millions in grants and sponsors going into research...
Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering
Pharmapack Europe has released a ‘European drug delivery and packaging’ report, ahead of the event’s opening which highlights, major challenges and opportunities for the industry in the year ahead...
Pricing dispute over cystic fibrosis drug Orkambi continues in the UK
Campaigners call for UK Government to intervene on pricing dispute over cystic fibrosis drug Orkambi...
Psoriasis treatment linked to improvement in heart disease
Treatments for psoriasis could help prevent heart disease in patients with the skin condition, with patients having an 8 percent reduction in their risk...
Compounded pain creams ‘no better than placebo’ for pain relief
Researchers find no evidence of effectiveness in three compounded topical pain creams specially formulated to treat localised chronic pain...
Efforts to advance the development of complex generic drugs
The FDA has issued a statement to promote the development of complex generic drugs to ensure access for patients and healthy drug competition...
Late-stage pipeline drugs could compete with only treatment for SMA
A number of drugs currently in their late stages in the development process could see competition for nusinersen, the only current SMA treatment, rise...
